The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

Two bills heard in a state Senate committee are designed to lower prices, provide fair competition for independent pharmacies ...

RFK Jr.'s call to ban TV advertisements for prescription drugs reignited support for a bipartisan bill that would mandate the ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Like many industries preparing for Donald Trump's second term as president, the prospects for the healthcare industry are a ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Teva Pharmaceuticals challenges the Inflation Reduction Act, arguing CMS's drug pricing policies harm generics, biosimilars, ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Teva Pharmaceutical Industries sues CMS over Medicare drug pricing negotiations policy, claiming agency has unchecked ...